| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 02/13/2007 | US7176180 Fusion proteins; immunoglobulins; kits |
| 02/13/2007 | US7176164 1,3-selenazolin derivatives and process for preparing the same |
| 02/13/2007 | US7175997 BMP-11 compositions |
| 02/13/2007 | US7175859 aqueous extract of stems or leaves or stems and leaves of one or more Cissus quandragularis plants to promote weight loss; combined with chitosan and amylase inhibitor |
| 02/13/2007 | US7175842 Methods of modulating hair growth |
| 02/13/2007 | US7175840 Compositions for gene therapy of rheumatoid arthritis including a gene encoding an anti-angiogenic protein or parts thereof |
| 02/13/2007 | CA2463976C N-substituted hydroxypyrimidinone carboxamide inhibitors of hiv integrase |
| 02/13/2007 | CA2359510C .omega.-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors |
| 02/13/2007 | CA2358840C Methods and kits comprising an estrogen agonist/antagonist for improving vascular health |
| 02/13/2007 | CA2285037C Novel 2-(iminomethyl)amino-phenyl derivatives, preparation, application as medicines and pharmaceutical compositions containing same |
| 02/13/2007 | CA2254759C Inhibitors of prenyl transferases |
| 02/13/2007 | CA2220649C 4-hydroxy-piperidine derivatives |
| 02/13/2007 | CA2124958C Inhibitory immunoglobulin polypeptides to human pdgf beta receptor |
| 02/13/2007 | CA2122236C Quinolines and their analogs |
| 02/08/2007 | WO2007016679A2 Combination immediate release controlled release levodopa and carbidopa dosage forms |
| 02/08/2007 | WO2007015587A1 Apoptosis promoter, cell proliferation inhibitor, prophylactic/therapeutic agent for cancer, screening method for the promoter, inhibitor or agent |
| 02/08/2007 | WO2007015578A1 Method for assay on the effect of vascularization inhibitor |
| 02/08/2007 | WO2007015546A1 Mesenchymal stem cell inducer, tissue regeneration promoter and method of preparing mesenchymal stem cell |
| 02/08/2007 | WO2006078422A3 Methods for modulating tumor growth and metastasis |
| 02/08/2007 | US20070032653 N-{1-(4-(3-bromophenyl)-1H-imidazol-2-yl)-5-methylhexyl}-N-cyclohexylamine; agonists or antagonists of somatostatin receptors; acromegaly, restenosis, Crohn's disease, systemic sclerosis, external and internal pancreatic pseudocysts and ascites, nesidoblastosis, hyperinsulinism, gastrinoma, etc. |
| 02/08/2007 | US20070032640 Cytokine receptor |
| 02/08/2007 | US20070032532 Hsp90 family protein inhibitors |
| 02/08/2007 | US20070032528 inhibitors of vascular endothelial growth factor receptor tyrosine kinase; antiproliferative agents; antitumor; 4-Hydroxy-3-(5-methylbenzimidazol-2-yl)hydropyridino[3,4-b]pyridin-2-one; nitrogen containing cyclic compounds |
| 02/08/2007 | US20070032525 e.g. (1H-benzoimidazol-2-yl)-[1-(3,4-dichloro-benzyl)-piperidin-4-ylmethyl]-amine; chemokine (C-C motif) receptor antagonist; antiallergen; asthma and allergic rhinitis, atopic dermatitis, urticaria, contact dermatitis, alleriric coniunctivitis, inflammatory bowel disease, AIDS, eosinqphilia |
| 02/08/2007 | US20070032518 Compounds and methods of use |
| 02/08/2007 | US20070032498 Use of pteridine derivatives for the treatment of increased intracranial pressure, secondary ischemia, and disorders associated with an increased level of cytotoxic reactive oxygen species |
| 02/08/2007 | US20070032446 Gapped 2' modified oligonucleotides |
| 02/08/2007 | US20070032433 Novel peptides as NS3-serine protease inhibitors of hepatitis C virus |
| 02/08/2007 | US20070031904 Mammalian IAP gene family, primers, probes and detection methods |
| 02/08/2007 | US20070031903 Mammalian IAP gene family, primers, probes and detection methods |
| 02/08/2007 | US20070031896 Anti-CCR4 antibodies and methods of use therefor |
| 02/08/2007 | US20070031888 Human leucine-rich repeat containing protein expressed predominately in small intestine, HLRRSI1 |
| 02/08/2007 | US20070031860 G-protein coupled receptor and uses therefor |
| 02/08/2007 | US20070031506 Interleukin-18 inducer |
| 02/08/2007 | US20070031502 Pharmaceutical composition for the treatment of acute disorders |
| 02/08/2007 | US20070031484 Immunoliposomes that optimize internationalization into target cells |
| 02/08/2007 | US20070031433 Tumor antigen |
| 02/08/2007 | US20070031432 Tumor antigen |
| 02/08/2007 | US20070031431 polypeptides consisting of amino acid sequences or peptide fragments and drug carriers, used for inducing and/or activating human leukocyte antigens (HLA-A2)-restricted tumor-specific cytotoxic T lymphocytes; anticancer vaccines |
| 02/08/2007 | US20070031400 Dichloroacetate in combination with clinically high levels of cardioprotective or hemodynamic drugs |
| 02/08/2007 | US20070031396 Method of treating neurological diseases |
| 02/08/2007 | DE19930177B4 Intermolekular assoziierende Verbindungen und deren Verwendung Inter-molecular associative compounds and their use |
| 02/08/2007 | CA2615209A1 Mc4r-ag0nists for the treatment of urinary tract dysfunction |
| 02/07/2007 | EP1749886A2 Polypeptides having kinase activity, their preparation and use |
| 02/07/2007 | EP1749836A2 Recombinant vascular endothelial cell growth factor D (VEGF-D) |
| 02/07/2007 | EP1749818A2 Phenyl-piperazine derivatives as serotonin reuptake inhibitors |
| 02/07/2007 | EP1749543A1 Tissue regenerative composition |
| 02/07/2007 | EP1749539A2 Preventives or remedies for fatty liver |
| 02/07/2007 | EP1749538A1 Methods of inducing differentiation of regulatory t-cells and proliferating the same with gpi anchor protein agonist and medicinal composition therefor |
| 02/07/2007 | EP1749534A2 Use of parasitic biological agents for prevention and control of autoimmune diseases |
| 02/07/2007 | EP1749530A2 Proteins involved in targeting of peptidyl transfer center, and corresponding therapeutic agents and methods [1998/31] |
| 02/07/2007 | EP1749529A1 Utilisation of heteroarene carboxamide as dopamine-D3 ligands for the treatment of CNS diseases |
| 02/07/2007 | EP1749522A2 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases |
| 02/07/2007 | EP1503765A4 Use of modulators of nicotinic receptors for treatment of cognitive dysfunction |
| 02/07/2007 | EP1457498B1 Novel peptide having angiotensin convertase inhibitory effect |
| 02/07/2007 | EP1401813B1 New indole derivatives with 5-ht6 receptor affinity |
| 02/07/2007 | EP1315501B1 Alpha v integrin receptor antagonists |
| 02/07/2007 | EP1261336B1 Il-8 receptor antagonists |
| 02/07/2007 | EP1242382B1 Tricyclic protein kinase inhibitors |
| 02/07/2007 | EP1231920B1 Use of epinastin for the treatment of allergic rhinitis/conjunctivitis |
| 02/07/2007 | EP1230241B1 Adenosine receptor antagonists and methods of making and using the same |
| 02/07/2007 | EP1228070B1 Heteroalkylamino-substituted bicyclic nitrogen heterocycles as inhibitors of p38 protein kinase |
| 02/07/2007 | EP1092029B1 Human thrombopoietin mutein |
| 02/07/2007 | EP1017680B1 Tricyclic compounds, preparation method and said method intermediates, application as medicines and pharmaceutical compositions containing same |
| 02/07/2007 | EP0998474B1 Piperazine derivatives |
| 02/07/2007 | CN1910176A Crystalline polymorph of a bisulfate salt of a thrombin receptor antagonist |
| 02/07/2007 | CN1908014A Modified peptides as therapeutic agents |
| 02/07/2007 | CN1907967A Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof |
| 02/07/2007 | CN1907481A Medicinal composition for treating summer heat-dampness rheum and preparation method thereof |
| 02/07/2007 | CN1907446A Health care pellet comprising animal and plant compositions capable of activating human body cells |
| 02/07/2007 | CN1907429A Method for preparing and controlling the quality of Chinese medicinal soft capsule |
| 02/07/2007 | CN1907409A Medicament for treating acute soft tissue injury and its preparation process |
| 02/07/2007 | CN1907395A Gen-seng computer tablet and method for its manufacture |
| 02/07/2007 | CN1907387A Novel clinical use of yiqi clever granule |
| 02/07/2007 | CN1907342A Navel-applying medicine for treating post partum night sweat and its preparation method |
| 02/07/2007 | CN1907321A Medicinal composition for treating exterior deficiency and preparation method thereof |
| 02/07/2007 | CN1298862C Glycoprotein and process for producing same |
| 02/07/2007 | CN1298719C Purine derivatives, preparation method and pharmaceutical compositions containing same |
| 02/07/2007 | CN1298717C Quinuclidine carbamate derivatives and their use as M3 antigonists |
| 02/07/2007 | CN1298715C Non-imidazole compounds as histamine H3 antagonists |
| 02/07/2007 | CN1298707C Imidazole and benzimiddzole caspase inhibitors and uses thereof |
| 02/07/2007 | CN1298705C Novel piperidine-4-sulfamide compound, its preparing method and medicinal composition containing them |
| 02/07/2007 | CN1298703C Cyanopyrolidine derivatives |
| 02/07/2007 | CN1298688C Technique for extracting and preparing policosanol and application |
| 02/07/2007 | CN1298355C Ready prepared Chinese medicine for antiaging and remitting body fatigue |
| 02/07/2007 | CN1298324C Naphthyridine derivatives, their preparation and their use as phosphodiesterase isoenzyme 4 (PDE4) inhibitors |
| 02/07/2007 | CN1298323C Fused pyrrolocarbazoles against inflammation |
| 02/07/2007 | CN1298320C Esmolol formulation |
| 02/07/2007 | CN1298319C Method for increasing intestinal absorption of fat soluble vitamins in post-menopausal women and lower animals |
| 02/06/2007 | US7173122 Antisense oligonucleotides to type I procollagen |
| 02/06/2007 | US7173109 Peptide sequence derived from the ghrelin polypeptide, coupled to a cystine amino acid, labeled with a fluorescent dye; used in high throughput screening to identify and characterize cellular receptors |
| 02/06/2007 | US7173056 Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligands |
| 02/06/2007 | US7173052 Resorcinol for lightening skin removing color |
| 02/06/2007 | US7173047 Benzo (f) insoindol derivatives and their use as ep4 receptor ligands |
| 02/06/2007 | US7173042 Quinoline inhibitors of cGMP phosphodiesterase |
| 02/06/2007 | US7173040 4-phenyl-6-alpha-(imidazolyl-, 1,2,4-triazolyl- or pyridyl)-benzyl substituted |
| 02/06/2007 | US7173038 Treatment of diseases such as cancer or arthritis |
| 02/06/2007 | US7173035 Arylsulfonamide compounds |
| 02/06/2007 | US7173033 Nitrogen-containing heterocyclic compound |
| 02/06/2007 | US7173028 Pyrimidine derivatives |